RS&RS Scientific and Native Labs are the newest arrivals to check in to Stevenage Bioscience Catalyst’s Lab Hotel to accelerate their R&D in a shared, collaborative space designed to help fledging therapeutics companies grow.
RS&RS Scientific is a pioneering research organisation dedicated to advancing healthcare through innovative solutions. With a focus on Small Cell Lung Cancer (SCLC) research, it is committed to making a positive impact on patients’ lives by uncovering groundbreaking treatments tailored to SCLC subtypes. Its team of experts is driven by a passion for scientific discovery and improving the prospects of individuals battling this devastating disease.
Reza Salimi, PhD, Founder, RS&RS Scientific, said: "We are thrilled to join the Lab Hotel community. The collaborative environment and state-of-the-art facilities provided here are instrumental in accelerating our research efforts. Being a part of this vibrant ecosystem aligns perfectly with our mission to revolutionize SCLC treatment."
Native Labs is on a mission to revolutionise bioprocessing. It believes that cellular-based products have the power to save and improve millions of lives. However, the road from prototype to commercialisation is a lengthy and costly one. Utilising the cutting edge in automation, data and AI, it is pioneering innovative solutions that streamline and supercharge bio-process development and manufacturing, enabling its customers to bring higher quality products to market faster, and cheaper.
Louis Brookstein, Founder, Native Labs, said: “The Lab Hotel will provide the space for Native Labs to begin generating AI training data, expediting our product development and allowing us to help our customers with their bioprocess development sooner. We can't wait to join the SBC community and for all the amazing opportunities this will bring.”
As part of SBC’s commitment to supporting early-stage start-ups, the Lab Hotel provides seven organisations with rent-free space for six months. The Lab Hotel offers each start-up access to two spaces in a laboratory which contains both molecular biology and mammalian tissue culture equipment. Being part of the Lab Hotel provides young companies with access to mentoring and introductions to the right investors for their stage of their development. It also enables them to work in a commercial rather than academic setting and interact with other organisations at a similar stage in their growth cycle.
Other current and former occupiers include: Genenet Technology; Genevation; Neobe Therapeutics; Inspira Pharmaceuticals; Serna Bio (formerly Ladder Therapeutics); Deliver Biosciences (formerly ImmTune Therapies); Nuntius Therapeutics; Stratosvir; Oppilotech and Exogene.
Since opening in 2012, SBC has hosted 92 companies in total, virtually and on site, with 89% of current and past occupiers continuing to prosper as opposed to the national 65-70% survival rate of start-ups. Companies also reported that product development was on average nine months faster thanks to be being based at SBC.
Dr Sally Ann Forsyth OBE, CEO, Stevenage Bioscience Catalyst, said: “I would like to extend a very warm welcome to our newest Lab Hotel arrivals. We pride ourselves on the quality of concierge services we offer at zero cost to enable fledgling companies to access the right scientific and business support to grow and benefit from being part of our vibrant life sciences community.”